HYTN Innovations Inc. has announced its successful export of cannabis to the United Kingdom's 4C LABS.
This announcement follows the news from November 28, 2024, that the Company received its first international order for products manufactured under its recently awarded Good Manufacturing Practices (GMP) designation.
The completed shipment of this first order includes the successful export, import, final packaging, and release for supply of 43.75 kilograms of cannabis flower for medical use. The company confirms that this initial order has been paid in full and that the products shipped are now available to patients across the UK through the country's regulated medical sales model.
Following this initial success, HYTN has received orders for immediate manufacture totaling over 500 kilograms of additional products, underscoring the growing demand for its premium cannabis-based pharmaceuticals in the international market.
For more information:
HYTN Innovations
hytn.ca/
4C Labs
4clabs.co/